Breaking News Instant updates and real-time market news.

AGN

Allergan

$159.51

5.05 (3.27%)

16:02
05/17/18
05/17
16:02
05/17/18
16:02

Allergan declined to discuss potential for Tepper activism, says Wells Fargo

Wells Fargo analyst David Maris spoke to Allergan after the Federal Trade Commission today granted antitrust clearance for David Tepper and his funds, Appaloosa Investment and Palomino Fund, in relation to the company. Allergan indicated the clearance provides flexibility to the filer as to whether it wants take an activist approach, Maris tells investors in a research note. When asked whether Appaloosa had reached out with specific changes it would like to see, Allergan indicated that it would not discuss any specific discussions it had with any shareholders or even confirm any talks took place, Maris adds. The analyst keeps an Outperform rating on Allergan. The stock in late afternoon trading is up 4% to $160.22.

AGN Allergan
$159.51

5.05 (3.27%)

05/01/18
DBAB
05/01/18
NO CHANGE
Target $210
DBAB
Buy
Deutsche continues to like the setup for Allergan shares
Deutsche Bank analyst Gregg Gilbert acknowledges the uncertainty regarding Allergan's strategic review but says he continues to like the setup for the shares. The analyst his earnings estimates based primarily on the Q1 outperformance and accelerated share repurchase. He keeps a Buy rating on Allergan with a $210 price target.
05/01/18
WELS
05/01/18
NO CHANGE
Target $240
WELS
Outperform
Allergan price target lowered to $240 from $245 at Wells Fargo
Wells Fargo analyst David Maris lowered his price target for Allergan to $240 from $245 following Q1 results and as investors seem to remain uncertain about Allergan's strategic direction. The analyst reiterates an Outperform rating on the shares.
05/07/18
CANT
05/07/18
NO CHANGE
CANT
Cantor positive on Evolus, Revance on potential to take Botox share
The potential launches of Evolus' (EOLS) DWP-450 in 2018 and Revance Therapeutics' (RVNC) RT002 in 2020 has investors wondering if less expensive and longer lasting toxins could take meaningful share away from Allergan's (AGN) Botox, Cantor Fitzgerald analyst Louise Chen tells investors in a research note. After speaking with two physicians who use 500-864 vials of Botox per year in their practices, the analyst reiterates Overweight ratings on Evolus and Revance and a Neutral rating on Allergan. Both doctors, who use Allergan's Botox in 95%-plus of their patients, said they would switch a large amount of their practice over to less expensive and/or longer acting toxins, if they are approved, Chen writes.
05/16/18
WELS
05/16/18
NO CHANGE
WELS
Outperform
Evolus CRL good news for Allergan, says Wells Fargo
Wells Fargo analyst David Maris noted that Evolus (EOLS) received a Complete Response Letter for its application for cosmetic neuro toxin candidate DWP-450, which he views as good news for Allergan (AGN) as the delay means Evolus will miss the 2018-2019 holiday season, which he points out is an important selling season for Botox. Maris, who also thinks Allergan may be able to use the CRL to "counter-detail" DWP-450 with doctors if the product does reach market, keeps an Outperform rating on Allergan shares.

TODAY'S FREE FLY STORIES

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
09/20/18
09/20
08:20
09/20/18
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$207.47

(0.00%)

08:20
09/20/18
09/20
08:20
09/20/18
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:20
09/20/18
09/20
08:20
09/20/18
08:20
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

08:20
09/20/18
09/20
08:20
09/20/18
08:20
General news
U.S. Philly Fed index preview: »

U.S. Philly Fed index…

08:20
09/20/18
09/20
08:20
09/20/18
08:20
General news
U.S. initial jobless claims preview: »

U.S. initial jobless…

TDOC

Teladoc

$75.40

-1.55 (-2.01%)

08:19
09/20/18
09/20
08:19
09/20/18
08:19
Recommendations
Teladoc analyst commentary  »

Teladoc price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

XLK

Technology Select Sector SPDR

$74.29

-0.17 (-0.23%)

08:19
09/20/18
09/20
08:19
09/20/18
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$75.13

0.24 (0.32%)

08:19
09/20/18
09/20
08:19
09/20/18
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTWK

NetSol Technologies

$5.90

0.15 (2.61%)

08:19
09/20/18
09/20
08:19
09/20/18
08:19
Hot Stocks
NetSol Technologies secures multi-million dollar contract with automaker »

NetSol Technologies has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ADSK

Autodesk

$148.42

-0.41 (-0.28%)

08:19
09/20/18
09/20
08:19
09/20/18
08:19
Recommendations
Autodesk analyst commentary  »

Autodesk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

XLY

Consumer Discretionary Sector SPDR

$116.98

(0.00%)

08:19
09/20/18
09/20
08:19
09/20/18
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$60.34

0.665 (1.11%)

08:19
09/20/18
09/20
08:19
09/20/18
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THO

Thor Industries

$105.72

2.44 (2.36%)

08:18
09/20/18
09/20
08:18
09/20/18
08:18
Technical Analysis
Technical Take: Thor Industries drops sharply after earnings »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$53.22

-1.15 (-2.12%)

08:18
09/20/18
09/20
08:18
09/20/18
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$54.63

-0.09 (-0.16%)

08:18
09/20/18
09/20
08:18
09/20/18
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$93.61

-0.1 (-0.11%)

08:18
09/20/18
09/20
08:18
09/20/18
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$169.64

-0.6 (-0.35%)

08:18
09/20/18
09/20
08:18
09/20/18
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$264.42

1.55 (0.59%)

08:17
09/20/18
09/20
08:17
09/20/18
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRO

Brown & Brown

$30.40

0.31 (1.03%)

08:17
09/20/18
09/20
08:17
09/20/18
08:17
Recommendations
Brown & Brown analyst commentary  »

Brown & Brown to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$291.22

0.26 (0.09%)

08:17
09/20/18
09/20
08:17
09/20/18
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NNBR

NN, Inc.

$15.80

0.1 (0.64%)

08:17
09/20/18
09/20
08:17
09/20/18
08:17
Conference/Events
NN, Inc. to host two day investor day »

Two day investor day to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 06

    Nov

XLF

Financial Select Sector

$28.74

0.485 (1.72%)

08:17
09/20/18
09/20
08:17
09/20/18
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$106.27

0.23 (0.22%)

08:16
09/20/18
09/20
08:16
09/20/18
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRBP

Corbus Pharmaceuticals

$5.15

0.025 (0.49%)

08:16
09/20/18
09/20
08:16
09/20/18
08:16
Conference/Events
Corbus Pharmaceuticals to hold a conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 01

    Oct

QQQ

Invesco QQQ Trust

$182.71

-0.11 (-0.06%)

08:16
09/20/18
09/20
08:16
09/20/18
08:16
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.